European Monitoring Centre for Drugs and Drug Addiction, Europol. (2024) EU drug market: heroin and other opioids — in-depth analysis.

European Monitoring Centre for Drugs and Drug Addiction. (2024) Drug-related research.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Drug policy evaluation in Europe — topic overview.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Xchange prevention registry.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] World AIDS Day: concerns over stimulant injecting and late HIV diagnoses in Europe. (30 Nov 2023)

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2023) EU drug market: cannabis — in-depth analysis.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Comorbid substance use and mental health problems.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Viral hepatitis elimination barometer among people who inject drugs — European overview.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2023) EU drug market: amphetamine — In-depth analysis.

de Schutter, Astrid and Duquet, Nils and Vanden Auweele, Dennis (2023) The nexus between drug markets and gun violence in the European Union. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on... Drug checking.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Addressing sexual health issues associated with drug use.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Fentanils and other new opioids.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Non-medical use of benzodiazepines.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Performance- and image-enhancing drugs.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Most recent data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Drug consumption rooms.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Frequently asked questions (FAQ): drug overdose deaths in Europe (topic overview).

European Monitoring Centre for Drugs and Drug Addiction. (2023) Homelessness and drugs: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. DOI: 10.2810/841350.

[EMCDDA] New legislation grants Europe stronger powers to tackle current and future drug problems. (30 Jun 2023)

European Monitoring Centre for Drugs and Drug Addiction. (2023) EMCDDA statistical bulletin - data and statistics on the drug situation in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Cannabis laws in Europe: questions and answers for policymaking. Luxembourg: Publications Office of the European Union. 10.2810/151113.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Dashboard: Prevalence of cocaine use in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2023) EMCDDA: General report of activities 2022 – key achievements and governance: a year in review. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. DOI: 10.2810/268534.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Wastewater analysis and drugs — a European multi-city study.

European Monitoring Centre for Drugs and Drug Addiction. Ujváry, István and Evans-Brown, Michael and Gallegos, Ana and Planchuelo, Gregorio and de Morais, Joanna and Christie, Rachel and Jorge, Rita and Sedefov, Roumen (2023) Hexahydrocannabinol (HHC) and related substances. Technical report. Luxembourg: Office for Official Publications of the European Communities. DOI: 10.2810/852912.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Prevention toolkit.

European Monitoring Centre for Drugs and Drug Addiction. (2023) EMCDDA webinar: Responding to stimulant use — developments in treatment. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Women and drugs: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Single programming document 2023–2025. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Cannabis policy hub.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Drugnet Europe. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2023) EMCDDA Best practice portal.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Hepatitis and drug use.

(2023) Irish national focal point.

European Monitoring Centre for Drugs and Drug Addiction. (2023) Law topics overview.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids. (19 Dec 2022)

European Monitoring Centre for Drugs and Drug Addiction. (2022) Families of people who use drugs: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. Matias, Joao (2022) Monitoring drug use in the digital age: studies in web surveys. European web survey on drugs: an overview of the project. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Spotlight on… Synthetic cannabinoids.

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA webinar: How wastewater monitoring can boost preparedness for new health threats. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Drug-related health and security threats in the Western Balkans. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Overview of drug markets in the European Neighbourhood Policy-South and Policy-East countries. Regional reports. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Recreational use of nitrous oxide: a growing concern for Europe. Luxembourg: Publications Office of the European Union. 10.2810/2003.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Topic overview: penalties at a glance.

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA trendspotter briefing. Responsiveness and preparedness in addressing drug-related needs of displaced Ukrainians in EU countries bordering Ukraine. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. DOI: 10.2810/847636.

European Monitoring Centre for Drugs and Drug Addiction. (2022) European drug report 2022: trends and developments. Luxembourg: Publications Office of the European Union. DOI: 10.2810/75644.

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA webinar: Drug consumption rooms in Europe - different realities, challenges and what to expect in the future. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA webinar: Knowing youth — digital platforms for decision making (ESPAD and beyond). EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Infographic: synthetic cathinones notifications to the Early Warning System and seizures.

Kardena, Alexandra and Strizek, Julian (2022) Monitoring drug use in the digital age: studies in web surveys. The potential for using web surveys to investigate drug sales through cryptomarkets on the darknet. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Belackova, Vendula and Drapalova, Eva (2022) Monitoring drug use in the digital age: studies in web surveys. Web surveys as a method for collecting information on patterns of drug use and supply. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2022) New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union. DOI: 10.2810/396103.

Winstock, Adam R and Davies, Emma L and Ferris, Jason A and Maier, Larissa J and Barratt, Monica J (2022) Using the Global Drug Survey for harm reduction. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA webinar: Workplaces and drugs – issues and challenges for the future. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Local communities and drugs: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] Hair drug testing — an innovative method for monitoring drug use. (28 Mar 2022)

[EMCDDA] European Commission adopts measures to control two harmful new drugs amidst health concerns and surge in supply. (21 Mar 2022)

European Monitoring Centre for Drugs and Drug Addiction. (2022) Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Luxembourg: Publications Office of the European Union. Risk assessment 35. DOI: 10.2810/671114.

European Monitoring Centre for Drugs and Drug Addiction. (2022) Risk assessment of new psychoactive substances (NPS).

European Monitoring Centre for Drugs and Drug Addiction. (2022) Recreational settings and drugs: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2022) How to run a trends workshop: an EMCDDA foresight toolkit for the drugs field. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] , Goosdeel, Alexis The changing face of Europe's drugs problem. (31 Jan 2022)

[EMCDDA] EMCDDA launches PLATO e-learning platform and virtual community of practice. (24 Jan 2022)

European Monitoring Centre for Drugs and Drug Addiction. (2022) Drug-related infectious disease (DRID): update from the expert network, October 2021. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2022) EMCDDA Single programming document 2022–2024. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Opioid-related deaths: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Drug-related infectious diseases: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Giraudon, Isabelle (2021) Drug-related deaths (DRD) in Europe: updates from the annual meeting of the EMCDDA DRD expert network 30 September – 1 October 2021. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) EMCDDA initial report on the new psychoactive substance 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) In accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Webinar: Cannabis control approaches across Europe. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Spotlight on… Understanding and using evidence.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Increase access to hepatitis C (HCV) testing and care in drug services — a toolkit.

Council of the European Union. (2021) EU Drugs action plan 2021-2025. Brussels: Council of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Manual: increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process. Luxembourg: Publications Office of the European Union. DOI 10.2810/033126.

Friis Søgaard, Thomas and Højlund Bræmer, Marie and Mulbjerg Pedersen, Michael (2021) Exploring drug supply, associated violence and exploitation of vulnerable groups in Denmark. Technical report. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] EMCDDA Best practice portal update (2/2021). School-based programmes to improve mental health and well-being and reduce risks. (15 Apr 2021)

European Monitoring Centre for Drugs and Drug Addiction. (2021) Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons: results from an EMCDDA trendspotter study. Luxembourg: Publications Office of the European Union.

[EMCDDA] EMCDDA launches 2021 European Web Survey on Drugs to assess patterns of drug use in over 30 countries. (18 Mar 2021)

European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dime- thylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) EMCDDA single programming document 2021–2023. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications. Technical report. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] EU presidency: Portugal focuses on Europe’s recovery and chairs activities in the field of drugs. (28 Jan 2021)

European Monitoring Centre for Drugs and Drug Addiction. (2021) Healthy nightlife toolbox.

European Monitoring Centre for Drugs and Drug Addiction. (2021) National drug-related public expenditure online resource.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA operating guidelines for the risk assessment of new psychoactive substances. Luxembourg: Publications Office of the European Union.

[EMCDDA] Recreational cannabis supply approved by voters in four US states but rejected in New Zealand. (07 Dec 2020)

European Monitoring Centre for Drugs and Drug Addiction. (2020) Reitox national focal points’ activities during the COVID-19 pandemic. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance methyl 2-({[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}amino)-3,3-dimethylbutanoate (4F-MDMB-BICA). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Drug-related homicide in Europe: data protocol, Technical report. Luxembourg: Office for Official Publications of the European Communities.

[EMCDDA] Looking back on 25 years of annual reporting on the drugs problem in Europe. (30 Sep 2020)

European Monitoring Centre for Drugs and Drug Addiction. (2020) European drug report 2020: key issues summary. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2020) European drug report 2020: trends and developments. Luxembourg: Publications Office of the European Union.

[EMCDDA] World Hepatitis Day: EMCDDA showcases hepatitis questionnaire for drug service staff to refresh knowledge and identify training needs. (28 Jul 2020)

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA technical report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene),. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2020) General report of activities 2019 – key achievements and governance: a year in review. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Monitoring and evaluating changes in cannabis policies insights from the Americas. Technical report. Luxembourg: Publications Office of the European Union.

Basra, Rajan (2019) Terrorism and drugs in Europe. Background paper commissioned by the EMCDDA for the EU drug markets report 2019. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Drug precursor developments in the European Union. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) EMCDDA pilot study of drug-related homicide in Finland, the Netherlands and Sweden. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2019) EU drug markets report 2019. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2019) Methamphetamine in Europe: EMCDDA-Europol threat assessment. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Using open-source information to improve the European drug monitoring system. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) European prevention curriculum: a handbook for decision-makers, opinion-makers and policy-makers in science-based prevention of substance use. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Prevention of drug-related deaths. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Drug-related deaths and mortality in Europe: update from the EMCDDA expert network. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Hepatitis C: new models of care for drugs services. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Jankovic, Jelena and Savic, Natasa (2019) Serbia Early warning system profile. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Developments in the European cannabis market. Luxembourg: Publications Office of the European Union. EMCDDA Papers.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Drug-related infectious diseases in Europe: update from the EMCDDA expert network. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) EMCDDA General report of activities 2018 – Key achievements and governance: a year in review. Lisbon: EMCDDA. doi: 10.2810/78849.

European Monitoring Centre for Drugs and Drug Addiction. (2019) EMCDDA Statistical bulletin 2019. Lisbon: EMCDDA.

[EMCDDA] WHO recommends rescheduling of cannabis. (25 Mar 2019)

European Monitoring Centre for Drugs and Drug Addiction. (2019) EMCDDA programming document 2019-21. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Improved drug supply indicators for Europe: progress report. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) m-Health applications for responding to drug use and associated harms. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Medical use of cannabis and cannabinoids: questions and answers for policymaking. Luxembourg: Publications Office of the European Union.

[EMCDDA] New legislation, bringing faster response to new drugs, applies from today. (23 Nov 2018)

European Monitoring Centre for Drugs and Drug Addiction, COPOLAD. (2018) Exploring new and emerging drug trends and developments in CELAC countries: joint report from the EMCDDA and COPOLAD workshop on trendspotter methodology. Lisbon: EMCDDA & COPOLAD.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Monitoring drug use in recreational settings across Europe: conceptual challenges and methodological innovations. Technical report. Luxembourg: Publications Office of the European Union. DOI: 10.2810/349958.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Captagon: understanding today's illicit market. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) HCV policies landscape in Europe. A compilation of national summaries and key-documents regarding HCV treatment and care for people who inject drugs from 28 EU countries and Norway. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Viral hepatitis policies in Europe. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

[EMCDDA] EMCDDA: resurgence of cocaine in a dynamic drug market. (07 Jun 2018)

European Monitoring Centre for Drugs and Drug Addiction. (2018) EMCDDA General report of activities 2017. Key achievements and governance: a year in review. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. doi: 10.2810/337732.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union.

[EMCDDA] Two new synthetic cannabinoids to be placed under control across the EU. (14 May 2018)

European Monitoring Centre for Drugs and Drug Addiction, Canadian Centre on Substance Use and Addiction. (2018) Cannabis and driving: questions and answers for policymaking. Luxembourg: Publications Office of the European Union.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. (2018) Public health guidance on active case finding of communicable diseases in prison settings. Stockholm and Lisbon: ECDC and EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) EMCDDA–Europol joint report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]acetamide (methoxyacetylfentanyl). Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Developing drug supply monitoring in Europe: current concepts. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

[EMCDDA] New legislation published today to bring faster response to new drugs. (21 Nov 2017)

[EMCDDA] Furanylfentanyl to be placed under control across the EU. (15 Nov 2017)

European Monitoring Centre for Drugs and Drug Addiction. (2017) Drug testing in schools. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2017) New developments in national drug strategies in Europe. Luxembourg: Publications Office of the European Union.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. (2017) Systematic review on active case finding of communicable diseases in prison settings. Stockholm: ECDC.

Almeida, Sara Rafael and Lourenço, Joana Sousa and Ciriolo, Emanuele (2017) Applying behavioural insights to drug policy and practice: opportunities and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Brunt, Tibor (2017) Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Blankers, Matthijs and Mujcic, Ajla (2017) E-health and m-health: using new technologies to respond to drug problems. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Evaluating drug policy: a seven-step guide to support the commissioning and managing of evaluations. Luxembourg: Publications Office of the European Union.

Sumnall, Harry and Bates, Geoff and Jones, Lisa (2017) Evidence review summary: drug demand reduction, treatment and harm reduction. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Bowden-Jones, O (2017) Joining up sexual health and drug services to better meet client needs. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Lemmens, Paul and Dupont, Hans and Roosen, Inez (2017) Migrants, asylum seekers and refugees: an overview of the literature relating to drug use and access to services. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Kilmer, Beau (2017) New developments in cannabis regulation. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Dale-Perera, annette (2017) Recovery, reintegration, abstinence, harm reduction: the role of different goals within the drug treatment in the European context. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Johnstone, Lauren and Liddell, David and Browne, Katie and Priyadarshi, Saket (2017) Responding to the needs of ageing drug users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Webster, Russell (2017) User-led interventions: an expanding resource? Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Arpa, Sharon (2017) Women who use drugs: Issues, needs, responses, challenges and implications for policy and practice. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

(2017) EMCDDA–Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Luxembourg: Publications Office of the European Union.

[EMCDDA] Preventing and reducing drug overdoses — a priority for the EMCDDA. (31 Aug 2017)

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl). Luxembourg: Publications Office of the European Union.

[EMCDDA] EMCDDA and ECDC join forces to address the challenge of hepatitis. (13 Jun 2017)

Millar, Tim and McAuley, Andrew (2017) EMCDDA assessment of drug-induced death data and contextual information in selected countries. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Bretteville-Jensen, Anne Line and Costa Storti, Claudia and Kattau, Thomas and Mikulic, Sania and Trigueiros, Fatima and Papamalis, Fivos and Piscociu, Laura and Tsarev, Sergey (2017) Public expenditure on supply reduction policies. Brussels: Council of Europe.

Montanari, Linda and Mravcik, Viktor and Grohmannova, Katerina and Royuela, Luis (2017) European questionnaire on drug use among prisoners (EQDP). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Legal approaches to drugs and driving. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Monitoring hospital emergencies and acute drug toxicity in Europe: Euro-DEN Plus network expands reach by welcoming eight new centres. (09 Mar 2017)

European Monitoring Centre for Drugs and Drug Addiction. (2017) Communities That Care (CTC): a comprehensive prevention approach for communities. Luxembourg: Publications Office of the European Union. DOI:10.2810/972747.

Fountain, Jane and Burkhart, Gregor and Montanari, Linda (2017) Implementation of drug-, alcohol- and tobacco-related brief interventions in the European Union Member States, Norway and Turkey. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. Risk Assessments 19.

European Monitoring Centre for Drugs and Drug Addiction. (2017) EU Justice and Home Affairs agencies’ cooperation in 2017. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Christin, Nicolas (2017) An EU-focused analysis of drug supply on the AlphaBay marketplace. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Christin, Nicolas (2017) An EU-focused analysis of drug supply on the online anonymous marketplace ecosystem. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] EU Council adopts its position on the reform of the new psychoactive substances legislation. (09 Dec 2016)

European Monitoring Centre for Drugs and Drug Addiction. (2016) Hospital emergency presentations and acute drug toxicity in Europe — update from the Euro-DEN Plus research group and the EMCDDA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA–Europol 2015 annual report on the implementation of Council Decision 2005/387/JHA. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Hepatitis C among drug users in Europe: epidemiology, treatment and prevention. Luxembourg: Publications Office of the European Union. EMCDDA Insights 23.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). Luxembourg: Publications Office of the European Union. Risk Assessments 18.

European Monitoring Centre for Drugs and Drug Addiction. (2016) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-l]acetamide (acetylfentanyl),. Luxembourg: Publications Office of the European Union. Joint reports.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Health responses to new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: health responses to new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: changes in Europe’s cannabis resin market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: cocaine trafficking to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2016) Assessing illicit drugs in wastewater: advances in wastewater-based drug epidemiology. Luxembourg: Publications Office of the European Union.

Strang, John and McDonald, Rebecca, eds. (2016) Preventing opioid overdose deaths with take-home naloxone. Luxembourg: Office for Official Publications of the European Communities. EMCDDA Insights Series no. 20.

England, Kathleen (2016) Codification practices of drug related deaths following the WHO revision of ICD coding guidelines related to DRDs – Part I. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

England, Kathleen (2016) A review of the inventory of the national Special Mortality Registries in Europe with a focus on information flow to the General Mortality Registries – Part II. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[EMCDDA] Minimum quality standards for drug demand reduction interventions in the EU. (28 Sep 2015)

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2015) EMCDDA–Europol joint report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP). Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Buhler, Anneke and Thrul, Johannes (2015) Prevention of addictive behaviours. Luxembourg: Publications Office of the European Union. EMCDDA Insights Series no. 18.

Hibell, Bjorn and Molinaro, Sabrina and Siciliano, Valeria and Kraus, Ludwig (2015) The ESPAD validity study in four countries in 2013. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Drugs policy and the city in Europe. Luxembourg: Office for Official Publications of the European Communities. EMCDDA Papers.

Sarasa-Renedo, Ana and Barrio, Gregorio and Montanari, Linda and Guarita, Bruno and de La Fuente, Luis and Bravo, Maria Jose and Vicente, Julian (2015) Estimating trends in injecting drug use in Europe using national data on drug treatment admissions. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Motion graphic: What is decriminalisation of drugs. EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction. (2015) New psychoactive substances in Europe: Innovative legal responses. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Legal approaches to controlling new psychoactive substances. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Models for the legal supply of cannabis: recent developments. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: opioid trafficking routes from Asia to Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: The misuse of benzodiazepines among high-risk opioid users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: The role of psychosocial interventions in drug treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Wastewater analysis and drugs — a European multi-city study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Hepatitis C treatment for injecting drug users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Injection of synthetic cathinones. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Preventing overdose deaths in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Synthetic drug production in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: The EU drugs strategy (2013–20). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Mortality among drug users in Europe: new and old challenges for public health. Luxembourg: Office for Official Publications of the European Communities.

[EMCDDA] Gaps in HIV prevention expose Europe to risk of outbreaks. (01 Dec 2014)

[EMCDDA] Four new drugs to be placed under control. (24 Sep 2014)

European Monitoring Centre for Drugs and Drug Addiction. (2014) Perspectives on drugs: Emergency health consequences of cocaine use in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Perspectives on drugs: Health and social responses for methamphetamine users in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Perspectives on drugs: Internet-based drug treatment. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Perspectives on drugs: New developments in Europe's cannabis market. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Perspectives on drugs: Treatment for cocaine dependence — reviewing current evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. Vanderplasschen, Wouter and Vandevelde, Stijn and Broekaert, Eric (2014) Therapeutic communities for treating addictions in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2014) The levels of use of opioids, amphetamines and cocaine and associated levels of harm: summary of scientific evidence. Luxembourg: Office for Official Publications of the European Communities.

[EMCDDA] Family can play vital role in addressing substance use disorders among adolescents. (06 Feb 2014)

[EMCDDA] EMCDDA hosts kick-off meeting of EC-funded Joint Action on Reducing Alcohol Related Harm. (31 Jan 2014)

European Monitoring Centre for Drugs and Drug Addiction. Brotherhood, Angelina and Sumnall, Harry (2013) European drug prevention quality standards: a quick guide. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Models of addiction. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2013) Perspectives on drugs: Can mass media campaigns prevent young people from using drugs? Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Driving under the influence of drugs, alcohol and medicines. New EMCDDA report reveals risks of substance use behind the wheel. (14 Dec 2012)

European Monitoring Centre for Drugs and Drug Addiction. (2012) Prisons and drugs in Europe: the problem and responses. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. Sumnall, Harry and Brotherhood, Angelina (2012) Social reintegration and employment: evidence and interventions for drug users in treatment. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) Guidelines for the evaluation of drug prevention: a manual for programme planners and evaluators. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] New ESPAD study shows overall stable drug use among school students and a reduction in ‘heavy episodic drinking’, but no decrease in cigarette smoking. (31 May 2012)

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA Trendspotter study on fentanyl in Europe. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine. Luxembourg: Publications Office of the European Union.

[EMCDDA] Drug use in Europe still a major threat to public health. (23 Jun 2011)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] Developing a set of indicators on drug markets, crime and supply reduction in Europe: your input is welcome. (13 May 2011)

EMCDDA, EUROPOL. [EMCDDA] New drugs becoming available at ‘unprecedented pace’, says report. (11 May 2011)

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. (2011) ECDC and EMCDDA guidance. Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC.

European Monitoring Centre for Drugs and Drug Addiction. (2011) EMCDDA manuals no 7. European drug prevention quality standards. A manual for prevention professionals. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Guidelines for the treatment of drug dependence: a European perspective. Luxembourg: Publications Office of the European Union. 10.2810/49457.

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. (2011) Prevention and control of infectious diseases among people who inject drugs. Stockholm: European Centre for Disease Prevention and Control.

[EMCDDA] EU drugs agency launches new guidelines for HIV testing in injecting drug users. (01 Dec 2010)

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA manuals no 4. Prevention and evaluation resources kit (PERK). Luxembourg: The Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Harm reduction: evidence, impacts and challenges. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA manuals no 5. Guidelines for collecting data on retail drug prices in Europe: issues and challenges. Luxembourg: The Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2010) EMCDDA manuals no 6. Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. A manual for provider-initiated voluntary medical examination, testing and counselling. Luxembourg: The Publications Office of the European Union.

Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups. Wiegand, Caren and Weilandt, Caren and MacDonald, Morag and Popov, Ivan and Purvlice, Baiba and Pavlovska, Linda and Parausanu, Emanual and Dobrota, Sorin (2010) Prison staff and harm reduction: a training manual. Bonn: Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups.

[EMCDDA] Council asks EMCDDA to assess risks of BZP. (24 Mar 2007)

European Monitoring Centre for Drugs and Drug Addiction. (2007) Guidelines for the evaluation of treatment in the field of problem drug use; a manual for researchers and professionals. Luxembourg: Office for Official Publications of the European Communities.

Buhler, Anneke and Kroger, Christoph (2006) Report on prevention of substance abuse. Cologne: Federal Centre for Health Education (BZgA). Research and Practice of Health Promotion, Volume 29.

Canning, Una and Millward, Louise and Raj, Thara and Warm, Daniel (2004) Drug use prevention among young people: a review of reviews. London: Health Development Agency.

Hawks, David and Scott, Katie and McBride, Myanda (2002) A selected review of what works in the area of prevention. Geneva: World Health Organization.

European Monitoring Centre for Drugs and Drug Addiction. (2001) Guidelines for the evaluation of outreach work: a manual for outreach practitioners. Luxembourg: Office for Official Publications of the European Communities.